$1.25
-0.02 (-1.57%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,656.0% upside
Low Target
$33.28
Average Target
$46.95
High Target
$64.49
Current Price
$1.25
Current
$1.25
$1.25
Target
$46.95
$46.95
$33.28
$46.95 avg
$64.49
Scenario Analysis
Bear Case
$33.28
2,562.4%
Low target
Base Case
$46.95
+3,656.0%
Avg target
Bull Case
$64.49
+5,059.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.40
-47.9% from high
52-Week Low
$1.02
+22.5% from low
Target vs 52W High
$46.95
+1,856.3% vs high
Next Earnings Report
Apr 6, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.22
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.9% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +157.7% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.5% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -69.0% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -12.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.5% |